Researchers at Queen Mary University of London have led the clinical development of the first non-integrase strand-transfer inhibitor (INSTI) single tablet treatment for HIV, among growing concern for ...

The devastating aids epidemic has claimed hundreds of thousands of lives—did you know that a sick chimpanzee is part of what ...

Broadly neutralizing antibodies, or bnAbs, are a long‑standing goal of HIV vaccine research because they can disable many strains of the virus at once.

One of the biggest hurdles in developing an HIV vaccine is coaxing the body to produce the right kind of immune cells and ...